Simultaneous Determination and Comparison of Phenolic Bioactives among Three Main Kinds of Edible Chrysanthemums.

In this study, we report a simple and reliable high-performance liquid chromatography coupled with diode array detection method for simultaneous and quantitative analysis and comparison of major phenolic compounds dominant phytochemicals in Chrysanthemum morifolium, Florists chrysanthemum and snow chrysanthemum (Coreopsis tinctoria or C. tinctoria). The chromatographic separation was achieved using a reversed phase C18 column with a mobile phase of water [containing 0.1% trifluoroacetic acid (TFA)] and acetonitrile. The major phenolic compounds were completely separated within 16 min at a flow rate of 1.0 mL/min. Flavonoid and phenolic acid profiles of the ethanol extracts of the three flowers were analyzed. The results revealed that C. tinctoria possessed the highest amount of flavonoids (flavanomarein, flavanokanin, marein and okanin) and relative lower content of phenolic acid (chlorogenic acid and 3,5-dicafeoylquinic acid). The total content of the four flavonoids in C. tinctoria reached 53.99 ± 1.32 mg/g. In particular, the marein content in C. tinctoria was as high as 36.50 mg/g. Flavanomarein was only detected in C. tinctoria, whereas chlorogenic acid and 3,5-dicafeoylquinic acid were abundant in Chrysanthemum morifolium and Florists chrysanthemum. The content of marein in Chrysanthemum morifolium was slightly higher than that in Florists chrysanthemum, whereas no okanin was detected in Florists chrysanthemum under these high-performance liquid chromatography conditions. The results indicated phenolic components differ significantly depending on the cultivar, especially between C. tinctoria and common commercially available chrysanthemums. The method adopted in this study is helpful for quality control of different chrysanthemum species as well as their products, which is essential for usage and functionality clarification.

Active Ingredients and Mechanism of Action of Rhizoma Coptidis against Type 2 Diabetes Based on Network-Pharmacology and Bioinformatics.

A pharmacological network of "component/target/pathway" for Rhizoma coptidis against type 2 diabetes (T2D) was established by network-pharmacology, and the active components of Rhizoma coptidis and its mechanism were explored. A literature-based and database study of the components of Rhizoma coptidis was carried out and screened by ADME parameters. The targets of Rhizoma coptidis were predicted by the ligand similarity method. Related pathways were analyzed with databases, and software was used to construct a "component/target/path" network. The mechanism was further confirmed by GEO database with R software. A total of 12 active components were screened from Rhizoma coptidis, involving 57 targets including MAPK1, STAT3, INSR, and 38 signaling pathways were associated with T2D. Related signaling pathways included essential pathways for T2D such as insulin resistance, and pathways that had indirect effect on T2D. It was suggested that Rhizoma coptidis may exert its effects against T2D through multi-component, multi-target, and multi-pathway forms.

A Novel Antiplatelet Aggregation Target of Justicidin B Obtained From Rostellularia Procumbens (L.) Nees.

The present study explored the possible bioactive ingredients and target protein of Rostellularia procumbens (L.) Nees. Firstly, we found that the ethyl acetate extraction obtained from R. procumbens could inhibit platelet aggregation. Then, gene chip was used to investigate differentially expressed genes and blood absorption compounds were investigated using high performance liquid chromatography-mass spectrometry characterization (LC-MS). Depending on the results of gene chip and LC-MS, the targets of blood absorption compounds were predicted according to the reverse pharmacophore matching model. The platelet aggregation-related genes were discovered in databases, and antiplatelet aggregation-related gene targets were selected through comparison. The functions of target genes and related pathways were analyzed and screened using the DAVID database, and the network was constructed using Cytoscape software. We found that integrin αIIbß3 had a highest degree, and it was almost the intersection of all pathways. Then, blood absorption compounds were screened by optical turbidimetry. Western blot (WB) revealed that justicidin B separated from the ethyl acetate fraction may inhibit the expression of integrin αIIbß3 protein. For the first time, we used Prometheus NT.48 and MST to detect the stability of this membrane protein to optimize the buffer and studied the interaction of justicidin B with its target protein. To our best knowledge, this is the first report to state that justicidin B targets the integrin αIIbß3 protein. We believe that our findings can provide a novel target protein for the further understanding of the mechanism of R. procumbens on platelet aggregation.